Sort
50,496 grants matching “lung cancer”
Synthetic lethality by targeting the core senescent mechanism in lung cancer.
$497,781Xiao-Fan Wang · Duke University · R01 · FY2020 · CA
Optimizing Lung Cancer Screening in World Trade Center Rescue and Recovery Workers
$497,701Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · OH
Anti-inflammatory role of MUC1 mucin
$497,638Kwang Chul Kim · Lovelace Biomedical & Environmental Research Institute · R01 · FY2007 · HL
Anti-inflammatory role of MUC1 mucin
$497,638Kwang Chul Kim · Lovelace Biomedical & Environmental Research Institute · R01 · FY2008 · HL
Improving the Timeliness and Quality of Care for Rural Lung and Head-and-Neck Cancer Patients
$497,623Evelinn Borrayo · University Of Colorado Denver · R01 · FY2024 · CA
TAS:: 75 0872:: TAS LUNG TISSUE RESEACH CONSORTIUM CLINICAL CENTER
$497,595Gerard J Criner · Temple Univ Of The Commonwealth · N01 · FY2011 · HL
FGF9 REGULATION OF LUNG DEVELOPMENT AND PATHOGENESIS OF PLEUROPULMONARY BLASTOMA
$497,577David M Ornitz · Washington University · R01 · FY2014 · HL
LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA
$497,575Anna Fernandez · Booz Allen Hamilton · N02 · FY2024 · CA
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer
$497,509Jacob Gardinier Scott · Cleveland Clinic Lerner Com-Cwru · R37 · FY2025 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment
$497,459Lauren Keith · Imbio, Llc · R44 · FY2017 · CA
A Personalized Digital Outreach Intervention for Lung Cancer Screening
$497,435David P Miller · Wake Forest University Health Sciences · R01 · FY2024 · CA
BIOMARKER VALIDATION LABORATORIES
$497,252University Of Alabama At Birmingham · U24 · FY2000 · CA
Targeting epigenetic reader GAS41
$497,243Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Targeting epigenetic reader GAS41
$497,243Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
$497,182Edna Cukierman · Research Inst Of Fox Chase Can Ctr · R01 · FY2024 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$497,137Paul Mathew · Tufts Medical Center · R01 · FY2024 · CA
Role of Mast cells in regulating inflammatory pathology of secondary lymphedema
$497,136Raghu Prasad Kataru · Sloan-Kettering Inst Can Research · R21 · FY2025 · AI
Role of the CTLH E3 ubiquitin ligase in breast cancer progression
$497,084Songhai Chen · University Of Iowa · R01 · FY2025 · CA
Role of the CTLH E3 ubiquitin ligase in breast cancer progression
$497,084Songhai Chen · University Of Iowa · R01 · FY2024 · CA
MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunity
$497,060Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
MERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunity
$497,060Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Mechanism and approach to inactivate mutant KRAS of lung metastatic colon cancer by RNA-ligand-displaying exosome to co-deliver dCas9--gRNA ribonucleoprotein complex and KRAS siRNA
$497,002Peixuan Guo · Ohio State University · R01 · FY2024 · CA
Project 3: From Networks and Structures to Hierarchical Whole Cell Models of Cancer
$496,996Trey Ideker · University Of California, San Francisco · U54 · FY2025 · CA
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
$496,995Alexander Sparreboom · Ohio State University · R01 · FY2019 · CA
Race,Treatment and Endometrial Cancer Survival
$496,981University Of Pennsylvania · R01 · FY2003 · CA